CRT 2026

EARLY FEASIBILITY STUDIES | STRUCTURAL

Moderator(s)

• 

  Samir R. Kapadia, MD, FSCAI

  Chairman, Cardiovascular Medicine
  Cleveland Clinic
  Cleveland, Ohio, United States

  Disclosure information not submitted.
• 

  Dee Dee Wang, MD

  Section Head Cardiac Imaging
  NCH Rooney Heart Institute, Michigan, United States

  Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing)

Panel Discussant(s)

• 

  Israel Barbash, MD

  Interventional Cardiologist
  Leviev Heart Center, Sheba Medical Center
  Shoham, HaMerkaz, Israel

  Disclosure(s): No financial relationships to disclose
• 

  Yair Feld, MD, PhD

  Director -Interventional cardiology
  Tzafon Medical Center (Poriya), Israel

  Disclosure(s): No financial relationships to disclose
• 

  Mayra E. Guerrero, MD, FACC, FSCAI

  Professor of Medicine
  Mayo Clinic Hospital
  Rochester, Minnesota, United States

  Disclosure(s): No financial relationships to disclose
• 

  Harun Kundi, MD

  Associate Scientific Director
  Cardiovascular Research Foundation, Texas, United States

  Disclosure(s): No financial relationships to disclose
• 

  Scott Lim, MD

  Professor of Medicine
  University of British Columbia
  Vancouver, British Columbia, Canada

  Disclosure information not submitted.
• 

  Ehud Raanani, MD

  Director of the Cardiothoracic and Vascular Center
  Sheba Medical Center
  Tel Hashomer, HaMerkaz, Israel

  Disclosure(s): Innovalve: Owner/Co-Owner Founder/Co-Founder (Ongoing)
• 

  Pradeep Yadav, MD

  Director of Structural Interventions
  Piedmont Atlanta Hospital
  Atlanta, Georgia, United States

  Disclosure information not submitted.